Crossover, Multiple Dose Pharmacokinetics of Two Curcumin Formulations in Healthy Volunteers
Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Area under plasma concentration curve from 0-48h using 13 time points.
Gary N Asher, MD, MPH
United States: Food and Drug Administration
|UNC Department of Family Medicine||Chapel Hill, North Carolina 27599|